1-(Adamantyl) amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
申请人:VERNALIS RESEARCH LIMITED
公开号:US20030130354A1
公开(公告)日:2003-07-10
Use of a compound of the formula (1), wherein X is an alkylene chain comprising 0, 1, 2, 3 or 4 carbon atoms; R
1
, R
2
and R
3
are independently selected from hydrogen, alkyl and aryl; R
4
, R
5
and R
6
are independently selected from hydrogen, alkyl, aryl, halogen and alkoxy; and prodrugs thereof and pharmaceutically acceptable salts thereof; in the manufacture of a medicament for use in the treatment of a condition generally associated with abnormalities in glutamatergic transmission.
使用公式(1)中的化合物,其中X是一个碳原子数为0、1、2、3或4的烷基链;R1、R2和R3分别选择自氢、烷基和芳基;R4、R5和R6分别选择自氢、烷基、芳基、卤素和烷氧基;以及它们的前药和药物可接受的盐;用于制造治疗通常与谷氨酸能传递异常有关的疾病的药物。